TMPRSS2 and COVID-19: Conversely, TMPRSS2 overexpression may justify the higher occurrence of COVID-19 complications in males, particularly in those with androgenetic alopecia (AGA), in which TMPRSS2 is likely more activated compared to non-AGA males [8, 9].